ArticleClinical pharmacology and therapeutics2022

Characteristics of the Compassionate Use Program in Japan: An Analysis of Expanded Access Clinical Trials from 2016 to 2021.

Hideki Maeda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.